Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Birzeit Pharmaceutical CoXPAE:BPC -9.27%77 Days Inventory is 277.80 as of Jun. 2026, which is 58% above its 10-year median of 176.03. GuruFocus rates XPAE:BPC with a GF Score™ of 77/100 and a GF Value™ of $4.33 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 918 Drug Manufacturers companies, Birzeit Pharmaceutical Co ranks worse than 54.36% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Birzeit Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.33.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Birzeit Pharmaceutical Co's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 1.48.
Birzeit Pharmaceutical Co (XPAE:BPC) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Birzeit Pharmaceutical Co's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Birzeit Pharmaceutical Co's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Birzeit Pharmaceutical Co Days Inventory Related Terms
Birzeit Pharmaceutical Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAE:BPC vs ZTS, UTHR, VTRS: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Birzeit Pharmaceutical Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Birzeit Pharmaceutical Co Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Birzeit Pharmaceutical Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Birzeit Pharmaceutical Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Birzeit Pharmaceutical Co (XPAE:BPC) has a Days Inventory of 277.80 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Birzeit Pharmaceutical Co and its competitors. This is 58% above median its historical median of 176.03. Over the past decade, Birzeit Pharmaceutical Co's Days Inventory has ranged from 144.52 to 216.48. According to the industry distribution chart, Birzeit Pharmaceutical Co ranks #499 out of 918 companies in the Drug Manufacturers industry, placing it in the top 54.4%.
Is Birzeit Pharmaceutical Co's Days Inventory too high?
Birzeit Pharmaceutical Co's current Days Inventory of 277.80 is 58% above median its 10-year median of 176.03. Over the past 10 years, this metric has ranged from a low of 144.52 to a high of 216.48. The Drug Manufacturers industry median Days Inventory is 164.53. Birzeit Pharmaceutical Co's value of 277.80 is 68.8% above this industry median. Based on the distribution chart, Birzeit Pharmaceutical Co ranks #499 out of 918 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Birzeit Pharmaceutical Co has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Birzeit Pharmaceutical Co's Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Birzeit Pharmaceutical Co ranks #499 out of 918 companies for Days Inventory. This places Birzeit Pharmaceutical Co in the lower half of its industry. The industry median Days Inventory is 164.53. Birzeit Pharmaceutical Co's value of 277.80 is 68.8% above this benchmark. Historically, Birzeit Pharmaceutical Co's own Days Inventory has ranged from 144.52 to 216.48 over the past decade. While the company's 10-year median is 176.03 vs. the industry median of 164.53, Birzeit Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.53, based on 918 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Birzeit Pharmaceutical Co's current Days Inventory of 277.80 is 68.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Birzeit Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Birzeit Pharmaceutical Co's current Days Inventory is 277.80, which is 58% above median its own 10-year median of 176.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Birzeit Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Birzeit Pharmaceutical Co (XPAE:BPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $4.33, compared to a current price of $3.62 — trading 16.4% below its estimated fair value. The current Days Inventory is 277.80, which is 58% above median its 10-year median of 176.03 and 68.8% above the Drug Manufacturers industry median of 164.53. Birzeit Pharmaceutical Co's overall GF Score™ is 77/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Birzeit Pharmaceutical Co (XPAE:BPC), the current Days Inventory is 277.80 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Birzeit Pharmaceutical Co (XPAE:BPC) Overvalued in 2026?
Based on GuruFocus' analysis, Birzeit Pharmaceutical Co stock appears to be undervalued.
The current stock price of $3.62 is trading 16.4% below its estimated GF Value™ of $4.33.
GuruFocus considers Birzeit Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for XPAE:BPC:
Days Inventory: 277.80 (58% above median its 10-year median of 176.03)
GF Value™: $4.33 vs. price of $3.62 (16.4% below fair value)
Industry Position: 68.8% above the Drug Manufacturers median (#499 of 918)
No single metric tells the full story. See the XPAE:BPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Birzeit Pharmaceutical Co operates as a pharmaceutical manufacturer in Palestine, producing a range of approximately 270 products across various production lines at four locations. Its portfolio comprises brands spanning multiple therapeutic areas. In addition to manufacturing, the company supplies its products to the local market through pharmacies and medical professionals.
77GF Score
Get the complete analysis for XPAE:BPC
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAE:BPC has been successfully added to your 
